American BioMed signs 3-year supply agreement with Joint Purchasing Corp. (JPC) to supply 380 hospitals.THE WOODLANDS, Texas--(BW HealthWire)--Feb. 5, 1997--American BioMed Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB:ABMI ABMI Autologous Bone Marrow Infusion ) Wednesday announced that it has signed a 3-year distribution agreement with Joint Purchasing Corp. JPC JPC Joint Parliamentary Committee (India) JPC John Paul College (Queensland, Australia) JPC Joint Propulsion Conference JPC Joint Planning Committee JPC Jpeg-2000 Code stream is a hospital buying group which represents 380 hospitals located in the tri-state New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of area. Product launch to all member hospitals is expected to begin within 30 days and to be completed over six months. The agreement includes American BioMed's 100% silicone balloon catheter balloon catheter n. A catheter with an inflatable balloon at its tip, used especially to expand a partially obstructed blood vessel or bodily passage and to measure blood pressure in a blood vessel. Also called balloon-tip catheter. line and its thermodilution catheters. Arthur S. Przybyl, VP Sales and Marketing, stated: "We are pleased that JPC has realized the importance of 100% silicone products and has recognized our product line's unique features and benefits. Specifically, there is no risk of adverse latex reaction when using American BioMed's silicone catheters in surgical procedures." The company anticipates an increase in its revenues for the first year of the agreement and substantial growth in subsequent years. American BioMed Inc. utilizes state of the art technology to develop, manufacture and market minimally invasive medical, surgical and diagnostic devices which deliver unique advantages through advanced science. Over 25 patents cover its technologies competing in an industry with combined markets estimated at over $10 billion annually. -0- NOTE TO EDITORS: In the Internet/email address noted in this news release, there is an "at" symbol tewinc and aol.com. This symbol may not appear properly in some systems. CONTACT: Thomas E. Waite & Associates Inc. 407/324-1606, fax 407/324-0664 Email: tewinc@aol.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion